Patents-Review.com
ClassID:

20967 ⎘

A61K38/2026 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interleukins [IL] IL-4

Recent Application in this class:
#1
20260125437
2026-05-07

FUSION PROTEIN COMPRISING IL13

 #2
20260083818
2026-03-26

System and Method for the Production, Formulation and Use of Conditioned Media, Cultured Cells and the Factors Included Therein

 #3
20260014096
2026-01-15

MEDICAL PATCH FOR CONTROLLED DELIVERY OF WOUND HEALING FACTORS AND THERAPIES

 #4
20250387480
2025-12-25

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND AUTOIMMUNE CONDITIONS WITH ECM-AFFINITY PEPTIDES LINKED TO ANTI-INFLAMMATORY AGENTS

 #5
20250339476
2025-11-06

ENGINEERED BACTERIAL THERAPEUTICS FOR THE TREATMENT OF GASTROINTESTINAL DISEASE

 #6
20250295736
2025-09-25

HIGHLY EFFECTIVE ADOPTIVE T CELL THERAPY

 #7
20250282843
2025-09-11

COMPOSITIONS COMPRISING AN INTERLEUKIN CONSTRUCT

 #8
20250276028
2025-09-04

COMPOSITION FOR REDUCING SIZE OR VOLUME OF TARGET TISSUE OR KIT INCLUDING SAME

 #9
20250195648
2025-06-19

THERAPEUTIC COMPOSITION AND METHOD COMBINING MULTIPLEX IMMUNOTHERAPY WITH CANCER VACCINE FOR THE TREATMENT OF CANCER

 #10
20250179690
2025-06-05

Split interleukin mimetics and their use

 #11
20250177376
2025-06-05

ALPHA 2 ADRENERGIC RECEPTOR BLOCKADE FOR THE TREATMENT OF C. DIFFICILE COLITIS

 #12
20250144150
2025-05-08

PREPARATION METHOD OF PHARMACEUTICAL COMPOSITION FOR TREATING CHRONIC STROKE

 #13
20250082728
2025-03-13

INTERLEUKIN 4 AND/OR INTERLEUKIN 13-BASED EYE COMPOSITIONS

 #14
20240424024
2024-12-26

PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES

 #15
20240399022
2024-12-05

COMPOSITIONS AND METHODS FOR MACROPHAGE CONVERSION

 #16
20240368293
2024-11-07

Methods of Improving Recovery After Lung Resection

 #17
20240352120
2024-10-24

COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET

 #18
20240285701
2024-08-29

COMPOSITIONS AND METHODS FOR TREATING SKIN CONDITIONS

 #19
20240269237
2024-08-15

PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES

 #20
20240261374
2024-08-08

PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES

 #21
20240226266
2024-07-11

METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS

 #22
20240197832
2024-06-20

METHODS AND MATERIALS FOR TREATING A STROKE

 #23
20240181009
2024-06-06

SYNTHEKINE COMPOSITIONS AND METHODS OF USE

 #24
20230405115
2023-12-21

COMBINATION THERAPY OF MDNA55 AND A VASCULAR ENDOTHELIAL GROWTH FACTOR A (VEGF-A)

 #25
20230364218
2023-11-16

METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS

 #26
20230330185
2023-10-19

METHODS AND COMPOSITIONS FOR TRANSDUCING HEMATOPOIETIC STEM AND PROGENITOR CELLS IN VIVO

 #27
20230225971
2023-07-20

STEM CELL-DERIVED EXOSOMES CONTAINING PAIN REGULATORS, AND USES THEREOF

 #28
20230076630
2023-03-09

MESENCHYMAL STEM CELLS AND USES THEREFOR

 #29
20230073125
2023-03-09

PERIODONTAL MICROPATCH AND USES THEREOF

 #30
20230070595
2023-03-09

Methods and compositions for producing an adenovirus vector for use with multiple vaccinations

 #31
20230060637
2023-03-02

MODULATING GAMMA-C-CYTOKINE ACTIVITY

 #32
20230025360
2023-01-26

PROCESSES FOR GENERATING SUPERIOR ANTI-TUMOR T-CELL EFFECTOR AND MEMORY CELLS

 #33
20220411492
2022-12-29

ANTIBODY AGAINST CLAUDIN 18A2 AND USE THEREOF

 #34
20220378877
2022-12-01

TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTIONS

 #35
20220372096
2022-11-24

Interleukin-4 Receptor-Binding Fusion Proteins and Uses Thereof

 #36
20220370593
2022-11-24

Methods and compositions for producing an adenovirus vector for use with multiple vaccinations

 #37
20220347268
2022-11-03

IL-4R AS A BIOMARKER IN CANCER

 #38
20220331111
2022-10-20

EXTENDED RELEASE IMMUNOMODULATORY IMPLANT TO FACILITATE BONE MORPHOGENESIS

 #39
20220273791
2022-09-01

SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION

 #40
20220265809
2022-08-25

Methods and compositions for producing an adenovirus vector for use with multiple vaccinations

 #41
20220257761
2022-08-18

Therapeutic composition and method combining multiplex immunotherapy with cancer vaccine for the treatment of cancer

 #42
20220249613
2022-08-11

CELL CULTURE FOR TREATING DISEASE IN THE LOWER LIMBS

 #43
20220249575
2022-08-11

FORMULATION AND TREATMENT FOR OPHTHALMIC DISORDERS

 #44
20220220179
2022-07-14

FUSION PROTEIN COMPRISING IL13

 #45
20220202996
2022-06-30

MEDICAL IMPLANT SURFACE-MODIFIED WITH FUNCTIONAL POLYPEPTIDE

 #46
20220162557
2022-05-26

Methods, compositions, and kits for producing beige adipocytes and treating metabolic disorders

 #47
20220152105
2022-05-19

T CELL RECEPTORS AND METHODS OF USE THEREOF

 #48
20220143145
2022-05-12

THERAPEUTIC CROSSLINKING OF CYTOKINE RECEPTORS

 #49
20220118089
2022-04-21

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND AUTOIMMUNE CONDITIONS WITH ECM-AFFINITY PEPTIDES LINKED TO ANTI-INFLAMMATORY AGENTS

 #50
20220110753
2022-04-14

EXTENDED RELEASE IMMUNOMODULATORY IMPLANT TO FACILITATE BONE MORPHOGENESIS

 #51
20220096655
2022-03-31

PLASMA POLYMER NANOPARTICLES CARRYING AGENTS

 #52
20220062383
2022-03-03

REGULATION OF A FOREIGN BODY RESPONSE

 #53
20220048965
2022-02-17

INTERLEUKIN-4 RECEPTOR-BINDING FUSION PROTEINS AND USES THEREOF

 #54
20220031741
2022-02-03

Methods and reagents for modulating macrophage phenotype

 #55
20220017588
2022-01-20

Split interleukin mimetics and their use

 #56
20210401941
2021-12-30

MULTILAYER DRUG DELIVERY COATING FOR CONTACT LENS

 #57
20210380690
2021-12-09

Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target

 #58
20210379021
2021-12-09

METHOD FOR PREPARING AND DELIVERING BISANTRENE FORMULATIONS

 #59
20210361825
2021-11-25

Compositions and methods for macrophage conversion

 #60
20210277083
2021-09-09

GM-CSF and IL-4 Conjugates, Compositions, and Methods Related Thereto

 #61
20210261639
2021-08-26

COMPOSITIONS COMPRISING AN INTERLEUKIN CONSTRUCT

 #62
20210260162
2021-08-26

SYNTHEKINE COMPOSITIONS AND METHODS OF USE

 #63
20210238293
2021-08-05

Method of treating IgG4-related disease

 #64
20210128689
2021-05-06

COMPOSITIONS AND METHODS FOR TREATING ALLERGIC DISORDERS

 #65
20210128637
2021-05-06

Methods for treating cardiac conditions

 #66
20210106731
2021-04-15

Layer by layer coated mesh for local release of bio-active proteins

 #67
20210106651
2021-04-15

BIO-MIMETIC FORMULATION

 #68
20200390861
2020-12-17

IL-4-fusion formulations for treatment of central nervous system (CNS) tumors

 #69
20200376137
2020-12-03

COMPOSITIONS AND METHODS RELATING TO MACROPHAGES AND/OR MONOCYTES WITH ADHERED PARTICLES

 #70
20200360442
2020-11-19

Mesenchymal stem cells and uses therefor

 #71
20200316262
2020-10-08

Extended release immunomodulatory implant to facilitate bone morphogenesis

 #72
20200316169
2020-10-08

System and Method for the Production, Formulation and Use of Conditioned Media, Cultured Cells and the Factors Included Therein

 #73
20200315800
2020-10-08

Extended release immunomodulatory implant to facilitate bone morphogenesis

 #74
20200276245
2020-09-03

Catalyst for the regeneration of tissues and related method for making it

 #75
20200261565
2020-08-20

Methods and compositions for producing an adenovirus vector for use with multiple vaccinations

 #76
20200246387
2020-08-06

Mesenchymal stem cells and uses therefor

 #77
20200215236
2020-07-09

Layer by layer coated mesh for local release of bio-active proteins

 #78
20200147178
2020-05-14

Fusion protein comprising IL-4 and IL-10

 #79
20200085876
2020-03-19

IMMUNOMODULATING CELL CIRCUITS

 #80
20200002419
2020-01-02

Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target

 #81
20190367879
2019-12-05

Composition for enhancing hair growth-inducing ability of adipose stem cells comprising udenafil as active ingredient

 #82
20190350890
2019-11-21

COMPOSITION FOR PREVENTING OR TREATING HEPATITIS CONTAINING MONOACETYL DIACYLGLYCEROL COMPOUND

 #83
20190316153
2019-10-17

Packaging cell for making a pseudotyped lentivirus

 #84
20190290688
2019-09-26

Methods and reagents for modulating macrophage phenotype

 #85
20190282692
2019-09-19

SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION

 #86
20190282616
2019-09-19

MACROPHAGES REDIRECT PHAGOCYTOSIS BY NON-PROFESSIONAL PHAGOCYTES AND INFLUENCE INFLAMMATION

 #87
20190270779
2019-09-05

Re-directed immunotherapy

 #88
20190264178
2019-08-29

Methods, compositions, and kits for producing beige adipocytes and treating metabolic disorders

 #89
20190255151
2019-08-22

Mesenchymal stem cells expressing anti-inflammatory cytokines and methods of use

 #90
20190240259
2019-08-08

Mesenchymal stem cells and uses therefor

 #91
20190224277
2019-07-25

BIO-MIMETIC FORMULATION

 #92
20190224239
2019-07-25

HEAT-EXPOSED PLATELET LYSATE COMPOSITIONS, AND METHODS FOR PREPARING AND USING SAME

 #93
20190216898
2019-07-18

Interleukin Combination and Use Thereof

 #94
20190216897
2019-07-18

Detection of CD5 and methods and compositions for modulating CD5

 #95
20190201447
2019-07-04

Mesenchymal stem cells and uses therefor

 #96
20190175657
2019-06-13

Mesenchymal stem cells and uses therefor

 #97
20190125796
2019-05-02

PROCESSES FOR GENERATING SUPERIOR ANTI-TUMOR T-CELL EFFECTOR AND MEMORY CELLS

 #98
20190100568
2019-04-04

Interleukin-4 receptor-binding fusion proteins and uses thereof

 #99
20190100567
2019-04-04

Interleukin-4 receptor-binding fusion proteins and uses thereof

 #100
20190099504
2019-04-04

Method for delivery of biological molecule to nervous tissue

 #101
20190076473
2019-03-14

AUTOLOGOUS AND ALLOGENIC MACROPHAGES AND MONOCYTES FOR USE IN THERAPEUTIC METHODS

 #102
20190070263
2019-03-07

Modulating gamma-c-cytokine activity

 #103
20190038800
2019-02-07

Methods for inducing macrophage conversion in a wound

 #104
20190016772
2019-01-17

GM-CSF and IL-4 conjugates, compositions, and methods related thereto

 #105
20190016764
2019-01-17

Fusion polypeptide in which anti-inflammatory polypeptide and ferritin monomer fragment are bound and pharmaceutical composition for preventing and treating inflammatory diseases, containing same as active ingredient

 #106
20190000890
2019-01-03

Placental tissue composition for for treating cardiac tissue damage

 #107
20180228775
2018-08-16

METHODS OF TREATING CANCER

 #108
20180179555
2018-06-28

Methods of delivering a pseudotyped lentivirus

 #109
20180179281
2018-06-28

COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET

 #110
20180117143
2018-05-03

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC REACTIONS

 #111
20180110837
2018-04-26

METHODS AND ASSAYS RELATING TO MACROPHAGE DIFFERENTIATION

 #112
20180100015
2018-04-12

COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET

 #113
20180094037
2018-04-05

Methods of treatment with a fusion protein comprising IL-4 and IL-10

 #114
20170320933
2017-11-09

Cytokine-based fusion proteins for treatment of immune disorders

 #115
20170290889
2017-10-12

METHODS AND COMPOSITIONS FOR TREATING DYSBIOSIS AND GASTROINTESTINAL AND INFLAMMATORY DISORDERS

 #116
20170266352
2017-09-21

Layer by layer coated mesh for local release of bio-active proteins

 #117
20170226173
2017-08-10

GM-CSF and IL-4 conjugates, compositions, and methods related thereto

 #118
20170202922
2017-07-20

TARGETED CARGO PROTEIN COMBINATION THERAPY

 #119
20170189496
2017-07-06

USE OF PHOSPHORYLATION PATHWAY-RELATED FACTOR IN REGULATING FUNCTION OF REGULATORY T CELL

 #120
20170112971
2017-04-27

BIOTIN-AVIDIN CONTROLLED DELIVERY SYSTEMS

 #121
20170087213
2017-03-30

Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, immunoglobulins and chemotactic factors

 #122
20170065706
2017-03-09

HPV vaccines and methods of use thereof

 #123
20170065693
2017-03-09

Breast cancer vaccines and methods of use thereof

 #124
20160361388
2016-12-15

METHOD AND COMPOSITION FOR THE TREATMENT OF MODERATE TO SEVERE KERATOCONJUNCTIVITIS SICCA

 #125
20160354472
2016-12-08

USE OF HUMAN SERUM ALBUMIN TO DECREASE ANTIGENICITY OF THERAPEUTIC PROTEINS

 #126
20160346385
2016-12-01

Granulysin in immunotherapy

 #127
20160340692
2016-11-24

Recombinant retrovirus pseudotyped with E2 alphavirus glycoprotein

 #128
20160317635
2016-11-03

Multivalent breast cancer vaccine

 #129
20160279286
2016-09-29

Compositions and methods for macrophage conversion

 #130
20160245816
2016-08-25

Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target

 #131
20160237135
2016-08-18

Interleukin-4 receptor-binding fusion proteins and uses thereof

 #132
20160215035
2016-07-28

Interleukin-4 receptor-binding fusion proteins and uses thereof

 #133
20160200789
2016-07-14

IL4 CONJUGATED TO ANTIBODIES AGAINST EXTRACELLULAR MATRIX COMPONENTS

 #134
20160199450
2016-07-14

SCAFFOLDS CONTAINING CYTOKINES FOR TISSUE ENGINEERING

 #135
20160184398
2016-06-30

Targeted cargo protein combination therapy

 #136
20160136239
2016-05-19

Method for producing autologous proteins

 #137
20160136205
2016-05-19

TARGETING TYPE I NKT CELLS TO CONTROL INFLAMMATION

 #138
20160120908
2016-05-05

Application of mesenchymal stem cells in prophylaxis or treatment of stress response-induced weakened immunity

 #139
20160106862
2016-04-21

Re-directed immunotherapy

 #140
20150297679
2015-10-22

METHODS AND ASSAYS RELATING TO MACROPHAGE DIFFERENTIATION

 #141
20150284444
2015-10-08

PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT INCLUDING FUSION PROTEIN

 #142
20150283183
2015-10-08

METHODS FOR TREATING CARDIAC CONDITIONS

 #143
20150250868
2015-09-10

Re-directed immunotherapy

 #144
20150246115
2015-09-03

Composition comprising cytokine macro-aggregates

 #145
20150238540
2015-08-27

Methods for treating cardiac conditions

 #146
20150196605
2015-07-16

Compositions and methods for preventing cardiac arrhythmia

 #147
20150164959
2015-06-18

Compositions and methods for preventing cardiac arrhythmia

 #148
20150150963
2015-06-04

VACCINATION WITH INTERLEUKIN-4 ANTAGONISTS

 #149
20150125421
2015-05-07

Cytokine-based fusion proteins for treatment of immune disorders

 #150
20150044165
2015-02-12

COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET

 #151
20150017255
2015-01-15

Methods for treating cardiac conditions

 #152
20150017132
2015-01-15

Mesenchymal stem cells and uses therefor

 #153
20150010497
2015-01-08

Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, and chemotactic factors

 #154
20140377217
2014-12-25

Sterilized and decellularized extracellular matrix for treating cardiac arrhythmia

 #155
20140335162
2014-11-13

PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC REACTIONS

 #156
20140328899
2014-11-06

Liposomes co-encapsulating a bisphosphonate and an amphipathic agent

 #157
20140294760
2014-10-02

Cell and therapeutical and diagnostical methods based thereon

 #158
20140193361
2014-07-10

Method to screen for an activator of adipose-resident NK cells

 #159
20140186294
2014-07-03

PHAGOCYTIC ACTIVITY AS A MARKER OF SYNUCLEINOPATHIC DISEASE

 #160
20140178474
2014-06-26

SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION

 #161
20140161776
2014-06-12

Mesenchymal stem cells and uses therefor

 #162
20140154276
2014-06-05

Mesenchymal stem cells and uses therefor

 #163
20140004081
2014-01-02

Re-directed immunotherapy

 #164
20130337044
2013-12-19

MODULATION OF EFFECTOR T CELL RESPONSES BY LOCAL DEPLETION OF COMPLEMENT COMPONENT C3

 #165
20130295047
2013-11-07

Method of treating inflammatory bowel disease by administering a clip-inducing agent

 #166
20130273002
2013-10-17

Multivalent breast cancer vaccine

 #167
20130236418
2013-09-12

Immunomodulatory methods and systems for treatment and/or prevention of aneurysms

 #168
20130230487
2013-09-05

Immunomodulatory methods and systems for treatment and/or prevention of hypertension

 #169
20130224144
2013-08-29

Sequential administration of a replication defective adenovirus vector in vaccination protocols

 #170
20130178425
2013-07-11

Methods and compositions for delivering interleukin-1 receptor antagonist

 #171
20130177525
2013-07-11

Cancer therapy based on tumor associated antigens derived from cyclin D1

 #172
20130171096
2013-07-04

Immunobinders directed against sclerostin

 #173
20130095062
2013-04-18

RECOMBINANT PRODUCTION OF AUTHENTIC HUMAN PROTEINS USING HUMAN CELL EXPRESSION SYSTEMS

 #174
20130058921
2013-03-07

USE OF AUTOLOGOUS EFFECTOR CELLS AND ANTIBODIES FOR TREATMENT OF MULTIPLE MYELOMA

 #175
20130052158
2013-02-28

USE OF AUTOLOGOUS EFFECTOR CELLS FOR TREATMENT OF MULTIPLE MYELOMA

 #176
20120294798
2012-11-22

METHODS OF TREATING CANCER USING IL-21

 #177
20120237475
2012-09-20

Inhibitors

 #178
20120225031
2012-09-06

SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONISTS IN THE TREATMENT OF DEMYELINATING DISORDERS

 #179
20120195854
2012-08-02

Granulysin in immunotherapy

 #180
20120177668
2012-07-12

IMMUNOMODULATING COMPOSITIONS COMPRISING INTERLEUKIN 13 INHIBITORS AND USES THEREFOR

 #181
20120164180
2012-06-28

Method of identifying tumor associated antigens

 #182
20120107282
2012-05-03

NEURAL STEM CELL COMPOSITION CAPABLE OF TREATING CANCER AND METHOD OF TREATMENT

 #183
20120071860
2012-03-22

Dendritic cell tumor injection (DCTI) therapy

 #184
20120070462
2012-03-22

Targeted gene delivery to dendritic cells

 #185
20120058082
2012-03-08

METHODS AND COMPOSITIONS FOR TREATMENT

 #186
20120027770
2012-02-02

Cell and therapeutical and diagnostical methods based thereon

 #187
20120027684
2012-02-02

Cancer therapy based on tumor associated antigens derived from cyclin D1

 #188
20110318315
2011-12-29

MESENCHYMAL STEM CELLS AND USES THEREFOR

 #189
20110318314
2011-12-29

MESENCHYMAL STEM CELLS AND USES THEREFOR

 #190
20110311496
2011-12-22

MESENCHYMAL STEM CELLS AND USES THEREFOR

 #191
20110300097
2011-12-08

Method And Composition For The Treatment Of Moderate To Severe Keratoconjunctivitis Sicca

 #192
20110287256
2011-11-24

PHARMACEUTICAL POLYPEPTIDE DRY POWDER AEROSOL FORMULATION AND METHOD OF PREPARATION

 #193
20110286959
2011-11-24

Copolymers for suppression of autoimmune diseases, and methods of use

 #194
20110284412
2011-11-24

PHARMACEUTICAL POLYPEPTIDE DRY POWDER AEROSOL FORMULATION AND METHOD OF PREPARATION

 #195
20110262393
2011-10-27

Composition comprising a culture solution of mesenchymal stem cells for the treatment of neural diseases

 #196
20110262384
2011-10-27

Pharmaceutical Polypeptide Dry Powder Aerosol Formulation and Method of Preparation

 #197
20110200620
2011-08-18

B7-H1 and methods of diagnosis, prognosis, and treatment of cancer

 #198
20110195112
2011-08-11

USE OF PLANT-DERIVED RECOMBINANT GROWTH FACTORS IN SKIN CARE

 #199
20110158939
2011-06-30

Methods and Compositions for Treating Asthma in Human and Nonhuman Primates

 #200
20110142807
2011-06-16

Mesenchymal Stem Cells and Uses Therefor

 #201
20110086002
2011-04-14

Restoration of hearing loss

 #202
20110081327
2011-04-07

Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection

 #203
20110070269
2011-03-24

LIPOPOLYSACCHARIDE ISOLATED FROM PYRULARIA TISSUE AND/OR PYRULARIA-ASSOCIATED BACTERIA AND USES THEREOF

 #204
20110053221
2011-03-03

Recombinant production of authentic human proteins using human cell expression systems

 #205
20110052532
2011-03-03

Pharmaceutical composition comprising a cytokine

 #206
20110052529
2011-03-03

METHODS AND COMPOSITIONS FOR EXPANDING T REGULATORY CELLS

 #207
20110027238
2011-02-03

Mesenchymal Stem Cells and Uses Therefor

 #208
20110021422
2011-01-27

Method and compositions for prevention and treatment of diabetic and aged skin

 #209
20110005523
2011-01-13

Pharmaceutical Polypeptide Dry Powder Aerosol Formulation and Method of Preparation

 #210
20110002882
2011-01-06

METHODS OF TREATING CANCER USING IL-21

 #211
20100322898
2010-12-23

METHODS OF TREATING CANCER USING IL-21

 #212
20100316600
2010-12-16

METHODS OF TREATING CANCER USING IL-21

 #213
20100316599
2010-12-16

METHODS OF TREATING CANCER USING IL-21

 #214
20100316598
2010-12-16

METHODS OF TREATING CANCER USING IL-21

 #215
20100316597
2010-12-16

METHODS OF TREATING CANCER USING IL-21

 #216
20100310505
2010-12-09

METHODS OF TREATING CANCER USING IL-21

 #217
20100233235
2010-09-16

Compositions and methods for preventing cardiac arrhythmia

 #218
20100233119
2010-09-16

Suppression of immune response to factor VIII in hemophilia A patients

 #219
20100210817
2010-08-19

Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use

 #220
20100203009
2010-08-12

Pathway for Th-17 Cell Development and Methods Utilizing Same

 #221
20100183673
2010-07-22

Sequential administration of a replication defective adenovirus vector in vaccination protocols

 #222
20100183545
2010-07-22

TARGETED CARGO PROTEIN COMBINATION THERAPY

 #223
20100183542
2010-07-22

Synergism Between Activated Immune Cells and Conventional Cancer Therapies

 #224
20100172885
2010-07-08

Multipotent Adult Stem Cells And Uses of Multipotent Adult Stem Cells To Treat Inflammation

 #225
20100172865
2010-07-08

METHODS OF ENHANCING HAIR GROWTH

 #226
20100135953
2010-06-03

Method of treatment of age-related macular degeneration

 #227
20100120140
2010-05-13

Recombiant lentivirus comprising an E2 alphavirus glycoprotein that binds to DC-SIGN

 #228
20100120122
2010-05-13

Packaging cells for producing retrovirus pseudotyped with an E2 alphavirus glycoprotein

 #229
20100113567
2010-05-06

Recombinant VSV For The Treatment of Tumor Cells

 #230
20100086515
2010-04-08

HUMAN IL-4 MUTEINS IN CANCER THERAPY

 #231
20100080769
2010-04-01

Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies

 #232
20100055070
2010-03-04

Cytokine-based fusion proteins for treatment of multiple sclerosis

 #233
20090324542
2009-12-31

SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONISTS IN THE TREATMENT OF DEMYELINATING DISORDERS

 #234
20090297475
2009-12-03

CYSTEINE DIOXYGENASE POLYMORPHISMS

 #235
20090281170
2009-11-12

POLYNUCLEOTIDE THERAPY

 #236
20090264515
2009-10-22

POLYNUCLEOTIDE THERAPY

 #237
20090246170
2009-10-01

Therapeutic Agent For Alzheimer's Disease

 #238
20090214494
2009-08-27

Cancer Vaccines and Therapeutic Methods

 #239
20090208463
2009-08-20

MESENCHYMAL STEM CELLS AND USES THEREFOR

 #240
20090202477
2009-08-13

Methods of treating viral infections using IL-21

 #241
20090191150
2009-07-30

METHODS OF TREATING INFECTIONS USING IL-21

 #242
20090180997
2009-07-16

Mesenchymal Stem Cells And Uses Therefor

 #243
20090136453
2009-05-28

Methods for treating pain

 #244
20090075886
2009-03-19

Dendritic cell stimulatory factor

 #245
20090074713
2009-03-19

Dendritic cell tumor injection (DCTI) therapy

 #246
20090074712
2009-03-19

Methods for Treatment and Prevention of Infection

 #247
20090060971
2009-03-05

Methods of treating a trauma or disorder of the knee joint by local administration and sustained-delivery of a biological agent

 #248
20090047242
2009-02-19

CONDITIONED BLOOD COMPOSITION AND METHOD FOR ITS PRODUCTION

 #249
20090010873
2009-01-08

Methods of Cell Therapy, Neurogenesis and Oligodendrogenesis

 #250
20080274098
2008-11-06

Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease

 #251
20080241100
2008-10-02

PHARMACEUTICAL COMPOSITION COMPRISING A CYTOKINE

 #252
20080241099
2008-10-02

Copolymers for suppression of autoimmune diseases, and methods of use

 #253
20080213227
2008-09-04

Mesenchymal stem cells and uses therefor

 #254
20080152652
2008-06-26

Ligand for the c-kit receptor and methods of use thereof

 #255
20080124308
2008-05-29

Gene Therapy of Solid Tumours by Means of Retroviral Vectors Pseudotyped With Arenavirus Glycoproteins

 #256
20080108559
2008-05-08

COMPOSITIONS AND METHODS FOR TREATING DISEASES THROUGH INHIBITION OF DNA METHYLATION AND HISTONE DEACETYLASE

 #257
20080075744
2008-03-27

Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine

 #258
20080057029
2008-03-06

Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine

 #259
20080019998
2008-01-24

Targeted gene delivery for dendritic cell vaccination

 #260
20070212308
2007-09-13

Methods for treating asthma in human and non human primates using IL-4 mutant compositions

 #261
20070172947
2007-07-26

Methods and compositions for expanding T regulatory cells

 #262
20070128161
2007-06-07

Methods of treating cancer using IL-21

 #263
20070128159
2007-06-07

CHEMOKINES AS ADJUVANTS OF IMMUNE RESPONSE

 #264
20070110714
2007-05-17

Medicinal composition for treatment of chronic hepatitis c

 #265
20070086980
2007-04-19

METHODS OF TREATING CANCER USING IL-21

 #266
20070059284
2007-03-15

METHODS OF TREATING INFECTIONS USING IL-21

 #267
20070049549
2007-03-01

METHODS OF TREATING CANCER USING IL-21

 #268
20070049548
2007-03-01

METHODS OF TREATING CANCER USING IL-21

 #269
20070048794
2007-03-01

Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use

 #270
20070048273
2007-03-01

Methods of treating cancer using IL-21

 #271
20070048272
2007-03-01

Methods of treating cancer using IL-21

 #272
20070048271
2007-03-01

Methos of treating cancer using IL-21

 #273
20070048270
2007-03-01

METHODS OF TREATING CANCER USING IL-21

 #274
20070048269
2007-03-01

METHODS OF TREATING CANCER USING IL-21

 #275
20070048268
2007-03-01

METHODS OF TREATING CANCER USING IL-21

 #276
20070048267
2007-03-01

METHODS OF TREATING CANCER USING IL-21

 #277
20070048266
2007-03-01

METHODS OF TREATING CANCER USING IL-21

 #278
20070041940
2007-02-22

METHODS OF TREATING CANCER USING IL-21

 #279
20070009479
2007-01-11

Methods for treating dermatitis using mutant human IL-4 compositions

 #280
20060292115
2006-12-28

Methods and compositions for treating and preventing inflammatory conditions

 #281
20060263355
2006-11-23

Treatment of bone disorders

 #282
20060263331
2006-11-23

Therapeutic use of tumor necrosis factor-alpha mutein

 #283
20060246032
2006-11-02

Chimeric IL-10

 #284
20060210552
2006-09-21

Compositions and methods for systemic inhibition of cartilage degradation

 #285
20060193824
2006-08-31

Methods for the treatment of infectious and inflammatory airway diseases

 #286
20060107353
2006-05-18

Plant bioreactors

 #287
20060083744
2006-04-20

B7-H1 and methods of diagnosis, prognosis, and treatment of cancer

 #288
20060046979
2006-03-02

Organic compounds

 #289
20060008446
2006-01-12

Methods for treating pain

 #290
20050276784
2005-12-15

Ligand for the c-kit receptor and methods of use thereof

 #291
20050256046
2005-11-17

Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use

 #292
20050239897
2005-10-27

Mesenchymal stem cells and uses therefor

 #293
20050159347
2005-07-21

Methods for treating hematological disorders through inhibition of DNA methylation and histone deacetylase

 #294
20050158341
2005-07-21

HIV-encoded chemoattractant

 #295
20050075298
2005-04-07

Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa

 #296
20050058624
2005-03-17

Chimeric IL-10 proteins and uses thereof

 #297
20050038233
2005-02-17

Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use

 #298
20050019305
2005-01-27

Methods of prevention and treatment of asthma, and allergic conditions

 #299
20050013800
2005-01-20

Methods of prevention and treatment of asthama, and allergic conditions

 #300
20050013799
2005-01-20

Methods of prevention and treatment of asthma, and allergic conditions